Covid-19 Rapid Test Cassette

Since December 2019, a series of unexplained pneumonia cases have been reported in Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily named this new virus, like the 2019 novel coronavirus (2019‐nCoV). The COVID‐19 epidemic is spreading all over the world. As a result, every sneeze or cough turned in to doubt in our minds. The hope of providing help for the prevention and control of the COVID‐19 epidemic.

The 2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of IgG and IgM antibodies to 2019-nCoV in whole blood, serum or plasma specimen.

This test consists of two components, an IgG and IgM component. In the IgG component, anti-human IgG is coated in IgG test line region, during testing the specimen reacts with 2019-nCoV antigen-coated particles in the test cassette. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgG, if the specimen contains IgG antibodies to 2019-nCoV a colored line will appear in IgG test line region as a result of this.

Similarly, anti-human IgM is coated in IgM test line region and if the specimen contains IgM antibodies to 2019-nCoV, the conjugate-specimen complex reacts with anti-human IgM as a result, a colored line appears in IgM test line region.

Therefore, if the specimen contains 2019-nCoV, a colored line will appear in both of IgG and IgM antibodies test line region. If the specimen does not contain 2019-nCoV antibodies, no colored line will appear in either of the test line regions, indicating a negative result.

To serve as a procedural control, a colored line will always appear in the (C)control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.